CMS Proposed Rule Aims at AMA-Designed Paperwork Burden,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
107
CMS Proposed Rule Aims at AMA-Designed Paperwork Burden, States the Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Centers for Medicare and Medicaid Services (CMS) has issued a Proposed Rule to “blend” payments for higher-level office visits, while decreasing the documentation requirements, as part of its Patients over Paperwork initiative. CMS claims this will save clinicians 51 hours per year —likely a gross underestimate—while critics protest that doctors will get paid the same for treating sniffles and cancer, notes the Association of American Physicians and Surgeons (AAPS).

The Rule is “budget neutral,” which means that it is a zero-sum game with winners and losers. The payment for any type of office visit of more than minimal complexity (level 2 through 5) will be between the current amounts for a level 3 and level 4.

“CMS observes that the Evaluation and Management (E/M) Documentation Guidelines have not been updated since 1997,” reports AAPS executive director Jane M. Orient. M.D. “They have a history that is worth recalling.”

“In 1997, the AMA released the 1997 update to its 1995 guidelines, with its copyright notice on every page. It was monstrously complex, with all kinds of ‘bullet points’ for different body systems and aspects of care that would have to be documented, repeatedly, on every visit, to claim higher levels of payment. There was so much outrage among physicians that the AMA held a “fly-in ” in Chicago on April 27, 1998, so that physician representatives from the AMA’s federation of medical societies could ‘vent.’

“Participants stated that the new guidelines increased transcription time by 20 percent, were a ‘complete waste,’ and increased gaming of the system.

“In her closing statement, president-elect Nancy Dickey, M.D ., said that the 1997 guidelines were on the ‘scrap heap,’ although physicians could use them if they chose.”

The Health Care Financing Administration (HCFA, renamed CMS) agreed to work for changes to avoid imposing an “undue burden” and to delay implementation —apparently until the energy for protesting died down, Dr. Orient observed.

Twenty years have now passed. “It is long past time for CMS to scrap these oppressive, time-devouring ‘guidelines,’ which are used to subject doctors to draconian civil and criminal penalties,” stated Dr. Orient.

The issue of payment for complex visits is being addressed by add-on codes for increased visit time, as CMS has explained in panel discussions. “Apparently, time is to be a proxy for massive cutting-and-pasting, and easier to audit because the number of hours in a day is limited,” Dr. Orient explained.

“The basic problem is the Byzantine system of Medicare price controls, with CMS using the AMA’s Resource-based Relative Value Scale to set prices for every Medicare encounter, instead of relying on free-market competition.”

The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties, founded in 1943.

Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Clermont Homebuyers Face Unexpected Hurdles

Updated Category News Views 52

Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 68

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 37

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
Sasol Names Stanley Subramoney as Audit Chair

Updated Category News Views 183

Shifting Sands at Sasol's Audit Helm Ah, the boardroom dance continues. Sasol has just announced, loud and clear from Johannesburg, that Mr. Stanley Subramoney is stepping up as the new Chairman of their Audit Committee. This is no small shuffle in the deck. When it comes to keeping the books in check at big players like Sasol, you need a top-tier audit leader. Ain't no...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 76

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 91

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
TIGR Investors Eye Class Action Amid Legal Woes

Updated Category News Views 69

A Legal Storm Brews Over UP Fintech When it rains, it pours, and for UP Fintech Holding Limited, the sky's looking pretty stormy. Investors who jumped on the NASDAQ:TIGR bandwagon between April 2024 and June 2026 are finding themselves at the center of a nasty legal maelstrom. The allegations? Well, they're explosive, hinting at a pattern of unlicensed cross-border...

Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout

Updated Category News Views 45

CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 79

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Class Action Looms Over The Chemours Company

Updated Category News Views 126

Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Polymer Foam Market Trends and Insights for 2025-2034

Updated Category News Views 255

Understanding the Polymer Foam Market The polymer foam market has witnessed significant growth recently, with a valuation of USD 151.19 billion in 2024 and expectations of reaching USD 273.58 billion by 2034. This growth corresponds to a compound annual growth rate (CAGR) of 6.11% from 2025 to 2034. A substantial portion of this expansion is influenced by the increasing...

Continue Reading
Renee Gala Takes the Helm as Jazz Pharmaceuticals CEO

Updated Category News Views 249

Renee Gala Takes on Leadership at Jazz Pharmaceuticals In an exciting development for Jazz Pharmaceuticals, the Board of Directors has announced the unanimous selection of Renee Gala as the new President and Chief Executive Officer. This pivotal decision is set to take effect shortly, marking a significant transition for the company as it continues to forge its path in...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 58

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Fidelity National Financial Launches New Consent Solicitation

Updated Category News Views 304

Introduction to Consent Solicitation Fidelity National Financial, Inc. (NYSE: FNF) has recently announced the commencement of separate consent solicitations for its various series of Senior Notes, an initiative that aims to amend the terms of its existing indenture agreements. The company holds four series of Senior Notes—4.500% due in 2028, 3.400% due in 2030, 2.450%...

Continue Reading
Legal Insights on Hims & Hers Health, Inc. Class Action Case

Updated Category News Views 179

Understanding the Hims & Hers Health, Inc. Securities Litigation The legal landscape surrounding Hims & Hers Health, Inc. has become a focal point for investors as the recent securities fraud lawsuit unfolds. Investors have an opportunity to engage in this case, which may hold significant implications for their investments. Why This Lawsuit Matters This lawsuit,...

Continue Reading